Healthy Living: Restoring diabetic pancreas
UC researcher discusses possible benefits of Ginkgo biloba
An article in the magazine Healthy Living discusses the latest research from Helal Fouad Hetta, PhD, a postdoctoral fellow and scientist in the UC Division of Digestive Diseases. Ginkgo biloba, a popular dietary supplement, may offer some therapeutic benefits in fighting Type 2 diabetes, according to Hetta. He is part of a team of more than a dozen international scientists who published a study on the effects of Ginkgo biloba in rats in the journal Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.
Helal Hetta, PhD
Hetta is also on faculty at Egypt’s Assiut University College of Medicine in the Department of Medical Microbiology and Immunology.
Hetta was also featured discussing his research on Cincinnati's WVXU radio station.
Related Stories
UC Board of Trustees approves $12 million for building design phase for new welcome gateway
March 13, 2026
The UC Board of Trustees approved $12 million at its Feb. 24 meeting for the design phase of a new Welcome Gateway Building for Uptown campus.
Breakthrough skin science discovery
March 12, 2026
A research collaboration between the University of Cincinnati and global cosmetics company Kose led to the creation of a novel anti aging spot fading serum.
Study: Additional radiation for liver cancer does not increase toxicity
March 10, 2026
New research led by University of Cincinnati Cancer Center researchers published in the American Journal of Clinical Oncology found external beam radiation therapy (EBRT) is safe to administer to patients with liver cancer even after they undergo a targeted internal radiation therapy called Y90.